Form 13-F position report

ISHARES TR

Reported by Florin Court Capital LLP

IBB CUSIP 464287556 Manager CIK 0001696263

Reported 64,100 shares, up 49,200 (330.2%) from the prior quarter.

Reported value 376.2%; share count 330.2% vs. the prior quarter.

Added
% of reported 13F value 13.92% This manager · Q3 2026
Shares 64,100 Quarter-end amount reported
Reported value $13,494,973 Fair value at quarter end
Consecutive quarters held 11 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 382000
2022-03-31 0
2024-03-31 2113188
2024-06-30 507862
2024-09-30 3610880
2024-12-31 0
2025-03-31 780190
2025-06-30 0
2025-09-30 11116490
2025-12-31 5079977
2026-03-31 1063755
2026-06-30 2833831
2026-09-30 13494973

Quarterly position history

How this manager's reported quarter-end position changed over time.

13 quarters
Quarterly reported position history for ISHARES TR held by Florin Court Capital LLP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 64,100 +49,200 (330.2%) 13.92% $13,494,973 2026-11-02
Q2 2026 Added 14,900 +8,600 (136.5%) 4.63% $2,833,831 2026-08-04
Q1 2026 Reduced 6,300 -23,800 (-79.1%) 4.01% $1,063,755 2026-05-06
Q4 2025 Reduced 30,100 -46,900 (-60.9%) 7.07% $5,079,977 2026-02-05
Q3 2025 New 77,000 +77,000 (0.0%) 8.71% $11,116,490 2025-11-03
Q2 2025 Reduced 0 -6,100 (-100.0%) 0 $0 2025-08-06
Q1 2025 New 6,100 +6,100 (0.0%) 0.81% $780,190 2025-05-12
Q4 2024 Reduced 0 -24,800 (-100.0%) 0 $0 2025-02-03
Q3 2024 Added 24,800 +21,100 (570.3%) 2.9% $3,610,880 2024-11-06
Q2 2024 Reduced 3,700 -11,700 (-76.0%) 0.7% $507,862 2024-08-05
Q1 2024 New 15,400 +15,400 (0.0%) 1.82% $2,113,188 2024-05-03
Q1 2022 Reduced 0 -2,500 (-100.0%) 0 $0 2022-05-03
Q4 2021 Added 2,500 +500 (25.0%) 0.24% $382,000 2022-02-02
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1087 managers reported ISHARES TR for Q3 2026.

Managers reporting ISHARES TR in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Bank of America Corporation Reduced 6,835,689 -39,442 0.09% $1,439,117,573 54 qtrs
Citigroup Inc Reduced 4,575,050 -185,659 0.31% $963,185,368 54 qtrs
MORGAN STANLEY Added 4,234,360 +913,383 0.05% $891,460,163 54 qtrs
The Goldman Sachs Group Inc Added 3,397,078 +2,220,901 0.06% $715,186,846 54 qtrs
BNP PARIBAS FINANCIAL MARKETS Added 2,459,477 +241,538 0.18% $517,793,693 51 qtrs
WELLS FARGO & COMPANY MN Added 1,087,313 +57,670 0.04% $228,911,995 54 qtrs
ENVESTNET ASSET MANAGEMENT INC Reduced 1,085,741 -36,918 0.05% $228,580,971 54 qtrs
RAYMOND JAMES FINANCIAL INC Reduced 980,688 -69,906 0.06% $206,464,093 8 qtrs
UBS Group AG Added 914,560 +52,187 0.03% $192,542,317 48 qtrs
LPL Financial LLC Added 910,613 +121,218 0.04% $191,711,269 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 02, 2026
Filing type
13F-HR
Position type
ISHARES BIOTECH

Voting authority reported

Sole
64,100
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.